Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Profound Medical	Cytosorbents	UFP Technologies	Acutus Medical	ClearPoint Neuro
Symbol	NASDAQ:PROF	NASDAQ:CTSO	NASDAQ:UFPT	NASDAQ:AFIB	NASDAQ:CLPT
Price Information
Current Price	$17.30	$8.14	$55.52	$13.33	$18.08
52 Week Range	Buy	Buy	Buy	Hold	Buy
MarketRank™
Overall Score	1.7	1.7	1.3	1.3	1.4
Analysis Score	3.6	3.5	0.0	3.1	3.5
Community Score	3.6	3.5	2.4	1.3	3.5
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.8	0.8	1.7	1.7	0.0
Earnings & Valuation Score	0.6	0.6	2.5	0.6	0.0
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Hold	Buy
Consensus Price Target	$29.67	$15.67	N/A	$24.80	$35.00
% Upside from Price Target	71.48% upside	92.47% upside	N/A	86.05% upside	93.58% upside
Trade Information
Market Cap	$342.12 million	$352.18 million	$417.90 million	$343.38 million	$357.95 million
Beta	1.45	0.36	0.92	N/A	1.15
Average Volume	80,270	325,701	29,154	336,778	429,597
Sales & Book Value
Annual Revenue	$4.17 million	$24.95 million	$198.38 million	$2.84 million	$11.22 million
Price / Sales	84.38	14.13	2.11	132.00	33.05
Cashflow	N/A	N/A	$4.27 per share	N/A	N/A
Price / Cash	N/A	N/A	12.99	N/A	N/A
Book Value	$0.92 per share	$0.11 per share	$21.78 per share	N/A	$0.30 per share
Price / Book	18.80	74.00	2.55	∞	60.27
Profitability
Net Income	$-15,220,000.00	$-19,270,000.00	$19.75 million	$-97,040,000.00	$-5,540,000.00
EPS	($1.37)	($0.60)	$2.63	N/A	($0.42)
Trailing P/E Ratio	N/A	N/A	27.76	0.00	N/A
Forward P/E Ratio	N/A	N/A	21.44	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-275.12%	-30.45%	8.12%	-1,410.17%	-55.55%
Return on Equity (ROE)	-33.69%	-34.37%	8.94%	N/A	-309.91%
Return on Assets (ROA)	-29.34%	-19.74%	7.67%	-74.36%	-34.06%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	0.07%	N/A	0.25%	118.51%
Current Ratio	28.03%	5.58%	4.27%	10.89%	5.42%
Quick Ratio	26.53%	5.46%	3.06%	10.21%	4.47%
Ownership Information
Institutional Ownership Percentage	35.90%	39.83%	76.06%	69.56%	6.61%
Insider Ownership Percentage	N/A	5.70%	11.00%	N/A	9.15%
Miscellaneous
Employees	109	195	860	291	67
Shares Outstanding	20.34 million	43.32 million	7.53 million	28.12 million	20.51 million
Next Earnings Date	8/5/2021 (Estimated)	8/3/2021 (Estimated)	8/3/2021 (Estimated)	9/16/2021 (Estimated)	8/11/2021 (Estimated)
Optionable	Optionable	Optionable	Not Optionable	Not Optionable	Not Optionable

Source	Headline
	ClearPoint Neuro, Inc. Expected to Earn Q4 2021 Earnings of ($0.11) Per Share (NASDAQ:CLPT) americanbankingnews.com - May 14 at 10:16 AM
	US$35.00 - That's What Analysts Think ClearPoint Neuro, Inc. (NASDAQ:CLPT) Is Worth After These Results finance.yahoo.com - May 13 at 9:23 AM
	Comparing STRATA Skin Sciences (NASDAQ:SSKN) & ClearPoint Neuro (NASDAQ:CLPT) americanbankingnews.com - May 12 at 3:18 PM
	ClearPoint Neuro (NASDAQ:CLPT) Releases FY 2021 Earnings Guidance americanbankingnews.com - May 12 at 1:48 PM
	ClearPoint Neuro, Inc. (CLPT) finance.yahoo.com - May 12 at 12:35 PM
	ClearPoint Neuro (NASDAQ:CLPT) Posts Earnings Results, Beats Expectations By $0.02 EPS americanbankingnews.com - May 12 at 12:24 PM
	ClearPoint Neuro, Inc. (CLPT) Q1 2021 Earnings Call Transcript fool.com - May 12 at 1:46 AM
	ClearPoint Neuro: Q1 Earnings Insights benzinga.com - May 11 at 9:22 PM
	ClearPoint Neuro Reports Record Revenue in First Quarter 2021 Results, Announces FDA Clearance ... apnews.com - May 11 at 4:22 PM
	ClearPoint Neuro Reports Record Revenue in First Quarter 2021 Results, Announces FDA Clearance of the SmartFrame ‘Array’ finance.yahoo.com - May 11 at 4:22 PM
	ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic ... apnews.com - May 11 at 11:22 AM
	ClearPoint Neuro Announces Partnership With D&K Engineering for Development of Robotic System for the MRI Suite and Operating Room finance.yahoo.com - May 10 at 7:00 PM
	ClearPoint Neuro Stock Is Estimated To Be Significantly Overvalued news.yahoo.com - May 8 at 7:12 PM
	Earnings Preview: ClearPoint Neuro, Inc. (CLPT) Q1 Earnings Expected to Decline finance.yahoo.com - May 4 at 8:24 PM
	ClearPoint Neuro (CLPT) to Release Earnings on Tuesday americanbankingnews.com - May 4 at 10:38 AM
	ClearPoint Neuro (NASDAQ:CLPT) & Accuray (NASDAQ:ARAY) Critical Survey americanbankingnews.com - May 4 at 6:22 AM
	Short Interest in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Rises By 23.9% americanbankingnews.com - May 4 at 3:46 AM
	ClearPoint Neuro to Announce First Quarter 2021 Results May 11, 2021 finance.yahoo.com - April 29 at 7:45 PM
	ClearPoint Neuro, Inc. Congratulates Voyager Therapeutics on FDA Clearance of IND Application for Gene Therapy Candidate VY-HTT01 for Treatment of Huntington’s Disease finance.yahoo.com - April 28 at 5:08 PM
	ClearPoint Neuro, Inc. (NASDAQ:CLPT): When Will It Breakeven? finance.yahoo.com - April 26 at 12:37 PM
	ClearPoint Neuro Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) finance.yahoo.com - April 23 at 7:50 PM
	Analysts Expect Breakeven For ClearPoint Neuro, Inc. (NASDAQ:CLPT) Before Long nasdaq.com - April 14 at 12:30 AM
	ClearPoint Neuro, Inc. Announces Retirement of Director John N. Spencer, Jr. finance.yahoo.com - April 13 at 7:30 PM
	ClearPoint Neuro, Inc. Congratulates uniQure on Completion of Enrollment in First Cohort of ... apnews.com - April 7 at 2:04 AM
	ClearPoint Neuro, Inc. Congratulates uniQure on Completion of Enrollment in First Cohort of Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease finance.yahoo.com - April 6 at 8:57 PM

Date	Company	Brokerage	Action
5/13/2021	Profound Medical	Alliance Global Partners	Lower Price Target
5/10/2021	Profound Medical	Raymond James	Set Price Target
3/4/2021	Profound Medical	Leede Jones Gab	Reiterated Rating
1/25/2021	Profound Medical	Lake Street Capital	Boost Price Target
9/15/2020	Profound Medical	Jefferies Financial Group	Initiated Coverage
4/7/2020	Profound Medical	Mackie	Downgrade
4/1/2020	Profound Medical	Cowen	Initiated Coverage
11/8/2019	Profound Medical	Echelon Wealth Partners	Reiterated Rating
1/4/2021	Cytosorbents	B. Riley	Boost Price Target
9/1/2020	Cytosorbents	SVB Leerink	Initiated Coverage
5/7/2020	Cytosorbents	Maxim Group	Initiated Coverage
5/6/2020	Cytosorbents	HC Wainwright	Boost Price Target
3/9/2020	Cytosorbents	Dawson James	Reiterated Rating
12/3/2020	UFP Technologies	Sidoti	Initiated Coverage
9/1/2020	UFP Technologies	Taglich Brothers	Reiterated Rating
3/25/2021	Acutus Medical	JPMorgan Chase & Co.	Reiterated Rating
3/25/2021	Acutus Medical	William Blair	Reiterated Rating
3/25/2021	Acutus Medical	Canaccord Genuity	Lower Price Target
1/14/2021	Acutus Medical	Bank of America	Downgrade
9/17/2020	Acutus Medical	BTIG Research	Reiterated Rating
3/12/2020	ClearPoint Neuro	Brookline Capital Management	Initiated Coverage

(Data available from 5/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources